Literature DB >> 4609909

Cholera toxoid boosts serum Escherichia coli antitoxin in humans.

D R Nalin, A al-Mahmud, G Curlin, A Ahmed, J Peterson.   

Abstract

Sera from individuals vaccinated with a cholera toxoid were tested to determine if sera with significant titers of cholera antitoxin could neutralize Escherichia coli thermolabile enterotoxin. Individuals who responded to immunization with significant increases in serum cholera antitoxin titers also showed increases in serum E. coli enterotoxin-neutralizing capacity. These findings suggested the possibility that the cholera toxoid vaccine may be useful in preventing disease caused by E. coli.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4609909      PMCID: PMC423016          DOI: 10.1128/iai.10.4.747-749.1974

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  6 in total

1.  PASSIVE SERUM PROTECTION OF THE INFANT RABBIT AGAINST EXPERIMENTAL CHOLERA.

Authors:  O R MCINTYRE; J C FEELEY
Journal:  J Infect Dis       Date:  1964-12       Impact factor: 5.226

2.  Diarrhea resembling cholera induced by Escherichia coli culture filtrate.

Authors:  D R Nalin; S H Richardson
Journal:  Lancet       Date:  1973-03-24       Impact factor: 79.321

3.  Diarrhoea resembling cholera induced by Escherichia coli culture filtrate.

Authors:  D R Nalin; S H Richardson; A K Bhattacharjee
Journal:  Lancet       Date:  1973-04-21       Impact factor: 79.321

4.  Titration of cholera antitoxin in human sera by microhemagglutination with formalinized erythrocytes.

Authors:  H D Hochstein; J C Feeley; W E DeWitt
Journal:  Appl Microbiol       Date:  1970-05

5.  Production of vascular permeability factor by enterotoxigenic Escherichia coli isolated from man.

Authors:  D J Evans; D G Evans; S L Gorbach
Journal:  Infect Immun       Date:  1973-11       Impact factor: 3.441

6.  Differences in the response of rabbit small intestine to heat-labile and heat-stable enterotoxins of Escherichia coli.

Authors:  D G Evans; D J Evans; N F Pierce
Journal:  Infect Immun       Date:  1973-06       Impact factor: 3.441

  6 in total
  7 in total

1.  Immunological cross-reactivity between a heat-labile enterotoxin(s) of Escherichia coli and subunits of Vibrio cholerae enterotoxin.

Authors:  J D Clements; R A Finkelstein
Journal:  Infect Immun       Date:  1978-09       Impact factor: 3.441

2.  Diarrhea caused by Escherichia coli that produce only heat-stable enterotoxin.

Authors:  M M Levine; E S Caplan; D Waterman; R A Cash; R B Hornick; M J Snyder
Journal:  Infect Immun       Date:  1977-07       Impact factor: 3.441

3.  Direct serological assay for the heat-labile enterotoxin of Escherichia coli, using passive immune hemolysis.

Authors:  D J Evans; D G Evans
Journal:  Infect Immun       Date:  1977-05       Impact factor: 3.441

4.  Humoral immune response to the heat-labile enterotoxin of Escherichia coli in naturally acquired diarrhea and antitoxin determination by passive immune hemolysis.

Authors:  D J Evans; G Ruiz-Palacios; D E Evans; H L DuPont; L K Pickering; J Olarte
Journal:  Infect Immun       Date:  1977-06       Impact factor: 3.441

5.  Immunological interrelationships between cholera toxin and the heat-labile and heat-stable enterotoxins of coliform bacteria.

Authors:  F A Klipstein; R F Engert
Journal:  Infect Immun       Date:  1977-10       Impact factor: 3.441

6.  Microtiter enzyme-linked immunosorbent assay for immunoglobulin G cholera antitoxin in humans: method and correlation with rabbit skin vascular permeability factor technique.

Authors:  C R Young; M M Levine; J P Craig; R Robins-Browne
Journal:  Infect Immun       Date:  1980-02       Impact factor: 3.441

7.  Development of a vaccine against experimental cholera and Escherichia coli diarrheal disease.

Authors:  R S Rappaport; G Bonde
Journal:  Infect Immun       Date:  1981-05       Impact factor: 3.441

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.